In summary, our study utilizes the generation of CAR constructs, and has shown a proof-of-concept that targeting antigen-specific CD8+ T cells using islet antigen-specific Tregs has a long-lasting effect to protect NOD mice from development of autoimmune diabetes, when given in the early stages of pathogenesis of diabetes. The gene discussed is CD8A; the disease is diabetes mellitus.